In a crucial development this week in the ongoing multidistrict litigation against Merck & Co., a federal judge in North Carolina granted the plaintiffs’ motion to compel adverse reaction data for the company’s Gardasil HPV-vaccine, which faces challenges to both its safety and efficacy.


Click Here To Read The Full Article